RecruitingNot ApplicableNCT07757529

Effect of Sage Extract Supplementation on Cognitive Function in Middle-Aged Men and Women

Effect of SageXtra Supplementation on Cognitive Function in Middle-Aged Men and Women


Sponsor

ESM Technologies, LLC

Enrollment

64 participants

Start Date

Feb 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Sage (Salvia officinalis) has been reported to have antioxidant, anti-inflammatory, and neuroprotective properties. Several studies indicate that sage supplementation can improve cognitive function. However, more research is needed. The purpose of this study is to examine how sage supplementation affects cognitive function and reaction times in middle-aged men and women.


Eligibility

Min Age: 40 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and SageXtra for people with cognitive ability, general. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTSageXtra

333 mg/day of SageXtra sage extract powder in two #0 capsules (167 mg/capsule).

DIETARY_SUPPLEMENTPlacebo

333 mg/day of methylcellulose powder in two #0 capsules.


Locations(1)

Exercise & Sport Nutrition Lab - Texas A&M University

College Station, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07757529


Related Trials